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When classes begin in the fall, young athletes often appear
in a cardiologist’s office because of the finding of abnormal
electrocardiography (ECG) results, a murmur, or some item
in the history that has triggered the consultation. Most
college and high school athletic programs require a medical
evaluation so that athletes are subjected in the United States
to a general examination that involves a history and a
physical examination. In Italy and most other countries of
Europe, in addition to the history and examination, a
resting ECG is mandated by law. In Israel, both a resting
ECG and a symptom-limited stress test are mandated (1).
See page 1291
The work of Corrado et al. (2) in Italy demonstrated a
decline in sports-related sudden death after ECG screening
was instituted in 1982. These results have been used to
develop screening programs in Europe, but these programs
have not been adopted in the United States. There are
several reasons for not using ECG screening in the United
States, mainly based on a cost-to-benefit ratio, but the data
of Maron et al. (3,4) from Minnesota show an already low
rate of sports-related sudden death and question the need
for ECG screening. In this issue of the Journal, Steinvil et
al. (1) challenge the Italian data on scientific grounds by
showing no difference in sudden death rate among high
school and college athletes before and after mandated ECG
and stress test screening that started in Israel in 1997. The
authors carefully reviewed newspaper reports for sudden
death during sports and found 24 cases (11 before screening
began, 13 after screening) that were not different in inci-
dence when comparing pre- and post-screening periods.
They raise the question of whether ECG screening is really
of value in reducing the rate of sudden death in sports.
The problem is compounded further by the low incidence
of sudden death in this population (2.6 events per 100,000
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pre-screened in Italy that was reduced to 0.4 events per
100,000 persons screened after 20 years of screening (1),
pproximately 1 event per 100,000 persons screened in
innesota (2,3), 6.5 events per 100,000 persons screened in
rance (5), and 1.2 events per 100,000 persons screened
n Denmark (6). Steinvil et al. (1) argue that their data are
ore representative because they sampled a 12-year pre-
creening period compared with the data of Corrado et al.
2), in which only 2 pre-screening years were used as
aseline. They suggest that the demand for screening
sually comes from public responses to an exceptionally
igh rate of sudden sports deaths, and the comparisons with
period of exceptionally high incidence then would provide
he appearance that screening actually reduced the death
ate. Their 12-year pre-screening sample suggests that there
s significant fluctuation of sports-related sudden death and
hat a longer average time is needed to understand the
mpact of screening. Steinvil et al. (1) also discuss the
oncept of immortality bias that may influence the screening
rocess. In this case, athletes at high risk who die before
creening is accomplished would not be counted in the
ohort, which then would seem to show a lower risk
ubsequent to screening. The 12-year pre-screening data to
ome extent would minimize the immortality bias, but the
teinvil et al. (1) data raise the question of what should be
he best method for reducing the already low rate of sudden
eath of athletes in the United States. A variety of cardiac
isorders can result in sudden death during sport activity.
hese include hypertrophic cardiomyopathy, arrhythmo-
enic right ventricular cardiomyopathy, Wolff-Parkinson-
hite syndrome, long QT syndrome, and Brugada syn-
rome (7). In athletes older than 35 years, coronary disease
ominates the sudden death diagnoses (8). Complex con-
enital heart disease and valvular heart disease usually are
nown to the patient and are detectable on physical exam-
nation, but the list provided above may be occult and
symptomatic until a sudden death event occurs. Com-
ounding the problem is the often variant nature (abnormal
s not the correct word here) of the ECG (9,10) or the
chocardiogram (11,12). Young athletes, particularly African-
merican males often have ECG findings that are not
ypical of the usual normal patient ECG found in a
ardiology practice (13). Tall voltages, ST-segment eleva-
ion typical of early repolarization, and T-wave inversions in
he right precordial region often lead to a diagnosis of
ardiomyopathy or ischemic heart disease. I personally have
ncountered healthy asymptomatic professional basketball
layers whose ECG was read as showing acute myocardial
nfarction and who were denied life insurance. They needed
eassurances that they were capable of playing professional
asketball, after a stellar career in college basketball. Pellic-
ia et al. (13) and Corrado et al. (14) examined the atypical
CG results in a group of athletes who died suddenly. They
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sensitivity was low. Distinguishing the atypical ECG results
of a young athlete from truly abnormal ECG results is an
important goal because the prevalence of such atypical ECG
results is high, and a complete evaluation of the heart
(echocardiography, MRI, CT, stress test, and so on) in
every one of these athletes could not be justified on the basis
of cost (15).
Similarly, screening of athletes with echocardiography
also will lead to a high number of false positive diagnoses
of cardiomyopathy. The atypical echocardiography find-
ings in an athlete are affected by the size of the athlete
and by the degree and type of training. Large athletes
often are clustered in basketball and football. It is not
uncommon to have athletes nearly 7 feet tall in basket-
ball. College and professional football players also are
taller than their age-related nonathletic counterparts.
Increased left ventricular diastolic diameter, increased
wall thickness, moderately enlarged right ventricle, trace
or mild tricuspid regurgitation, or mitral regurgitation all
can be found in athletes with no apparent increase in risk
for sudden death and no evidence of cardiomyopathy
(11,12). Here again, an extensive cardiac work-up based
on these findings will result in very high costs and likely
prohibition from sports for athletes who should not be
disqualified.
As of 2011, we do not have mandated ECG screening of
athletes in the United States. It is not clear if such screening
would reduce substantially the already low incidence of
sudden cardiovascular death that occurs during sports activ-
ity. Wheeler et al. (15) suggest that ECG screening added
to a history and physical examination would be cost effec-
tive, based on the Corrado et al. data, but their calculations
likely would be different based on the data of Steinvil et al.
(1), whose data challenge the concept that ECG screening
in fact would disqualify those who may be at risk. The
concern is that many athletes would be disqualified based on
false positive ECG findings (16,17), and we do not at
present have an inexpensive method for more accurate
screening of the millions of high school and college athletes
in the United States. Perhaps one solution would be to
support research to identify the specific gene or genes that
increase the sudden death risk and expect, when we all have
our total genome characterized, to select those individuals
for more detailed evaluation who express one or more of
those genes. This, however, is not feasible at present, but
likely will be in the future. At present, cardiologists who
evaluate athletes should be familiar with the normal variants
in echocardiography and ECG results (17–19) and should
incorporate the 12 questions posed by the American Heart
Association (20) for screening so that young athletes are not
disqualified based on variant ECG results or normal cardiac
adaptations to exercise.Reprint requests and correspondence: Dr. Alfred A. Bove,
Cardiology Section, Temple University School of Medicine, Par-
kinson Pavilion Suite 945, 3401 North Broad Street, Philadelphia,
Pennsylvania 19140-4105. E-mail: bovea@tuhs.temple.edu.
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